Surgepays Selling And Marketing Expenses vs Total Revenue Analysis

SURG Stock

USD 3.66 0.03 0.83%

Surgepays financial indicator trend analysis is much more than just breaking down Surgepays prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Surgepays is a good investment. Please check the relationship between Surgepays Selling And Marketing Expenses and its Total Revenue accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surgepays. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more detail on how to invest in Surgepays Stock please use our How to Invest in Surgepays guide.

Selling And Marketing Expenses vs Total Revenue

Selling And Marketing Expenses vs Total Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Surgepays Selling And Marketing Expenses account and Total Revenue. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Surgepays' Selling And Marketing Expenses and Total Revenue is -0.21. Overlapping area represents the amount of variation of Selling And Marketing Expenses that can explain the historical movement of Total Revenue in the same time period over historical financial statements of Surgepays, assuming nothing else is changed. The correlation between historical values of Surgepays' Selling And Marketing Expenses and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Selling And Marketing Expenses of Surgepays are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Selling And Marketing Expenses i.e., Surgepays' Selling And Marketing Expenses and Total Revenue go up and down completely randomly.

Correlation Coefficient

-0.21

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Selling And Marketing Expenses

Total Revenue

Total revenue comprises all receipts Surgepays generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Most indicators from Surgepays' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Surgepays current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surgepays. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more detail on how to invest in Surgepays Stock please use our How to Invest in Surgepays guide.At this time, Surgepays' Enterprise Value Multiple is most likely to increase significantly in the upcoming years. The Surgepays' current Enterprise Value is estimated to increase to about 86.9 M, while Issuance Of Capital Stock is projected to decrease to 516.75.

	2023	2024 (projected)
Interest Income	1.3M	1.1M
Reconciled Depreciation	1.1M	740.0K

Interest Income Reconciled Depreciation

Surgepays fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Non Current Assets Total	Non Currrent Assets Other	Short Long Term Debt Total	Property Plant And Equipment Net	Current Deferred Revenue	Net Receivables	Short Term Debt	Long Term Debt	Intangible Assets	Property Plant Equipment
Total Assets		0.44	0.79	0.85	-0.64	-0.64	0.83	0.97	0.97	0.99	0.38	-0.02	0.96	0.63	0.99	0.14	0.89	0.06	0.58	0.97	-0.39	0.98	0.7	0.3	0.5	0.94
Other Current Liab	0.44		0.72	0.03	0.1	-0.87	0.56	0.27	0.27	0.4	0.62	-0.09	0.58	0.8	0.44	0.09	0.38	0.33	0.62	0.45	0.05	0.46	0.16	0.66	0.44	0.52
Total Current Liabilities	0.79	0.72		0.37	-0.13	-0.86	0.89	0.64	0.64	0.77	0.58	0.01	0.79	0.93	0.75	0.06	0.83	0.33	0.82	0.84	-0.09	0.78	0.76	0.52	0.68	0.79
Total Stockholder Equity	0.85	0.03	0.37		-0.92	-0.21	0.49	0.94	0.94	0.87	-0.04	-0.18	0.78	0.14	0.88	0.09	0.62	-0.19	0.12	0.75	-0.57	0.83	0.47	-0.12	0.1	0.7
Net Debt	-0.64	0.1	-0.13	-0.92		-0.01	-0.21	-0.79	-0.79	-0.69	0.38	0.47	-0.58	0.13	-0.71	-0.06	-0.31	0.33	0.22	-0.5	0.66	-0.62	-0.26	0.43	0.25	-0.42
Retained Earnings	-0.64	-0.87	-0.86	-0.21	-0.01		-0.84	-0.51	-0.51	-0.57	-0.73	0.0	-0.78	-0.9	-0.6	-0.11	-0.69	-0.27	-0.85	-0.7	-0.05	-0.6	-0.53	-0.71	-0.69	-0.76
Accounts Payable	0.83	0.56	0.89	0.49	-0.21	-0.84		0.75	0.75	0.78	0.66	0.11	0.86	0.85	0.78	0.15	0.93	0.26	0.86	0.9	-0.16	0.78	0.79	0.57	0.76	0.91
Cash	0.97	0.27	0.64	0.94	-0.79	-0.51	0.75		1.0	0.96	0.21	-0.14	0.93	0.45	0.97	0.14	0.82	-0.05	0.42	0.92	-0.48	0.93	0.66	0.12	0.36	0.88
Cash And Short Term Investments	0.97	0.27	0.64	0.94	-0.79	-0.51	0.75	1.0		0.96	0.21	-0.14	0.93	0.45	0.97	0.14	0.82	-0.05	0.42	0.92	-0.48	0.93	0.66	0.12	0.36	0.88
Common Stock Shares Outstanding	0.99	0.4	0.77	0.87	-0.69	-0.57	0.78	0.96	0.96		0.29	-0.09	0.93	0.59	0.99	0.13	0.85	0.03	0.5	0.95	-0.44	0.98	0.69	0.2	0.42	0.89
Non Current Liabilities Total	0.38	0.62	0.58	-0.04	0.38	-0.73	0.66	0.21	0.21	0.29		0.65	0.44	0.78	0.31	0.21	0.6	0.3	0.88	0.49	0.27	0.4	0.24	0.98	0.82	0.64
Other Current Assets	-0.02	-0.09	0.01	-0.18	0.47	0.0	0.11	-0.14	-0.14	-0.09	0.65		-0.12	0.22	-0.1	0.09	0.25	0.13	0.44	0.07	0.32	0.04	-0.04	0.63	0.51	0.2
Other Stockholder Equity	0.96	0.58	0.79	0.78	-0.58	-0.78	0.86	0.93	0.93	0.93	0.44	-0.12		0.67	0.95	0.13	0.84	0.05	0.62	0.94	-0.33	0.92	0.65	0.38	0.51	0.94
Total Liab	0.63	0.8	0.93	0.14	0.13	-0.9	0.85	0.45	0.45	0.59	0.78	0.22	0.67		0.58	0.13	0.75	0.39	0.93	0.72	0.09	0.64	0.59	0.75	0.8	0.74
Total Current Assets	0.99	0.44	0.75	0.88	-0.71	-0.6	0.78	0.97	0.97	0.99	0.31	-0.1	0.95	0.58		0.11	0.83	0.02	0.5	0.94	-0.45	0.98	0.64	0.23	0.4	0.9
Common Stock	0.14	0.09	0.06	0.09	-0.06	-0.11	0.15	0.14	0.14	0.13	0.21	0.09	0.13	0.13	0.11		0.14	-0.3	0.14	0.2	0.13	0.09	-0.02	0.18	0.24	0.18
Non Current Assets Total	0.89	0.38	0.83	0.62	-0.31	-0.69	0.93	0.82	0.82	0.85	0.6	0.25	0.84	0.75	0.83	0.14		0.26	0.82	0.94	-0.13	0.85	0.84	0.5	0.79	0.94
Non Currrent Assets Other	0.06	0.33	0.33	-0.19	0.33	-0.27	0.26	-0.05	-0.05	0.03	0.3	0.13	0.05	0.39	0.02	-0.3	0.26		0.41	0.08	0.0	0.06	0.23	0.34	0.33	0.12
Short Long Term Debt Total	0.58	0.62	0.82	0.12	0.22	-0.85	0.86	0.42	0.42	0.5	0.88	0.44	0.62	0.93	0.5	0.14	0.82	0.41		0.7	0.19	0.56	0.63	0.84	0.93	0.77
Property Plant And Equipment Net	0.97	0.45	0.84	0.75	-0.5	-0.7	0.9	0.92	0.92	0.95	0.49	0.07	0.94	0.72	0.94	0.2	0.94	0.08	0.7		-0.31	0.94	0.78	0.39	0.63	0.96
Current Deferred Revenue	-0.39	0.05	-0.09	-0.57	0.66	-0.05	-0.16	-0.48	-0.48	-0.44	0.27	0.32	-0.33	0.09	-0.45	0.13	-0.13	0.0	0.19	-0.31		-0.4	-0.13	0.36	0.43	-0.23
Net Receivables	0.98	0.46	0.78	0.83	-0.62	-0.6	0.78	0.93	0.93	0.98	0.4	0.04	0.92	0.64	0.98	0.09	0.85	0.06	0.56	0.94	-0.4		0.62	0.32	0.46	0.91
Short Term Debt	0.7	0.16	0.76	0.47	-0.26	-0.53	0.79	0.66	0.66	0.69	0.24	-0.04	0.65	0.59	0.64	-0.02	0.84	0.23	0.63	0.78	-0.13	0.62		0.13	0.6	0.66
Long Term Debt	0.3	0.66	0.52	-0.12	0.43	-0.71	0.57	0.12	0.12	0.2	0.98	0.63	0.38	0.75	0.23	0.18	0.5	0.34	0.84	0.39	0.36	0.32	0.13		0.79	0.57
Intangible Assets	0.5	0.44	0.68	0.1	0.25	-0.69	0.76	0.36	0.36	0.42	0.82	0.51	0.51	0.8	0.4	0.24	0.79	0.33	0.93	0.63	0.43	0.46	0.6	0.79		0.69
Property Plant Equipment	0.94	0.52	0.79	0.7	-0.42	-0.76	0.91	0.88	0.88	0.89	0.64	0.2	0.94	0.74	0.9	0.18	0.94	0.12	0.77	0.96	-0.23	0.91	0.66	0.57	0.69

Click cells to compare fundamentals

Surgepays Account Relationship Matchups

Surgepays fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	10.0M	7.3M	19.5M	34.0M	42.1M	44.3M
Other Current Liab	678.0K	1.7M	8.0M	13.0M	570K	541.5K
Total Current Liabilities	7.1M	15.3M	10.0M	23.5M	12.7M	13.3M
Total Stockholder Equity	(4.7M)	(10.7M)	3.6M	5.0M	28.2M	29.7M
Net Debt	8.2M	7.0M	1.4M	1.1M	(9.2M)	(8.7M)
Retained Earnings	(10.9M)	(21.6M)	(35.1M)	(35.8M)	(15.2M)	(14.4M)
Accounts Payable	4.6M	7.3M	8.0M	7.5M	7.5M	7.9M
Cash	346.0K	674.0K	6.3M	7.0M	14.6M	15.4M
Cash And Short Term Investments	346.0K	674.0K	6.3M	7.0M	14.6M	15.4M
Common Stock Shares Outstanding	1.9M	2.1M	4.4M	12.4M	14.9M	15.7M
Liabilities And Stockholders Equity	10.0M	7.3M	19.5M	34.0M	42.1M	44.3M
Non Current Liabilities Total	7.6M	2.7M	6.0M	5.4M	1.0M	1.9M
Other Current Assets	1.4M	172.6B	5.6K	111.5K	161.9K	153.8K
Other Stockholder Equity	6.1M	10.7M	38.7M	40.8M	43.4M	45.6M
Total Liab	14.7M	18.1M	15.9M	28.9M	13.7M	7.7M
Total Current Assets	3.6M	1.3M	13.9M	27.6M	33.4M	35.0M
Common Stock	102.2K	127.1K	12.1K	14.1K	14.4K	15.1K
Non Current Assets Total	6.4M	6.1M	5.6M	6.4M	8.8M	9.2M
Non Currrent Assets Other	61.5K	66.5K	61.5K	176.9K	(539.4K)	(512.5K)
Short Long Term Debt Total	8.5M	7.7M	7.7M	8.1M	5.4M	3.8M
Property Plant And Equipment Net	505.4K	605.4K	687.1K	1.1M	1.3M	1.4M
Net Receivables	3.1M	393.1K	3.2M	9.2M	9.5M	10.0M
Short Term Debt	1.7M	5.8M	1.7M	2.7M	4.6M	4.9M
Other Assets	(4K)	66.5K	61.5K	176.9K	203.4K	213.5K
Long Term Debt	6.6M	1.7M	5.5M	5.0M	460.5K	437.5K
Inventory	(172.6B)	178.3K	4.4M	11.2M	9.0M	9.5M
Intangible Assets	4.8M	4.1M	3.4M	3.2M	2.7M	2.0M
Property Plant Equipment	31.0K	505.4K	236.8K	687.1K	790.2K	829.7K
Net Tangible Assets	(2.9M)	(10.3M)	(15.7M)	(749.2K)	(674.3K)	(708.0K)
Short Long Term Debt	2.1M	5.9M	1.7M	2.7M	4.6M	2.5M
Other Liab	883.6K	600.5K	869.9K	852.0K	979.8K	808.9K
Net Invested Capital	4.0M	(3.1M)	10.7M	12.7M	33.3M	35.0M
Net Working Capital	(3.5M)	(14.1M)	3.9M	4.1M	20.7M	21.7M
Capital Stock	115.9K	140.9K	12.3K	14.1K	14.4K	13.7K

Currently Active Assets on Macroaxis

V	Visa Class A
BAC	Bank of America
GM	General Motors
GOOG	Alphabet Inc Class C
CRM	Salesforce

When determining whether Surgepays is a strong investment it is important to analyze Surgepays' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Surgepays' future performance. For an informed investment choice regarding Surgepays Stock, refer to the following important reports:

How To Invest In Surgepays

Details

Is Surgepays Stock a good investment?

Details

What is Surgepays' Net Worth?

Details

Largest Wireless Telecommunication Services Companies

View

Largest Telecommunication Services Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surgepays. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more detail on how to invest in Surgepays Stock please use our How to Invest in Surgepays guide.

You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Complementary Tools for Surgepays Stock analysis

When running Surgepays' price analysis, check to measure Surgepays' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgepays is operating at the current time. Most of Surgepays' value examination focuses on studying past and present price action to predict the probability of Surgepays' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgepays' price. Additionally, you may evaluate how the addition of Surgepays to your portfolios can decrease your overall portfolio volatility.

	Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges
	Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
	My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk

Is Surgepays' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Surgepays. If investors know Surgepays will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Surgepays listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.78)

Earnings Share

1.14

Revenue Per Share

8.832

Quarterly Revenue Growth

(0.1)

Return On Assets

0.1806

The market value of Surgepays is measured differently than its book value, which is the value of Surgepays that is recorded on the company's balance sheet. Investors also form their own opinion of Surgepays' value that differs from its market value or its book value, called intrinsic value, which is Surgepays' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Surgepays' market value can be influenced by many factors that don't directly affect Surgepays' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Surgepays' value and its price as these two are different measures arrived at by different means. Investors typically determine if Surgepays is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Surgepays' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Surgepays Selling And Marketing Expenses vs Total Revenue Analysis

Selling And Marketing Expenses vs Total Revenue

Selling And Marketing Expenses vs Total Revenue Correlation Analysis

Correlation Coefficient

Selling And Marketing Expenses

Total Revenue

Surgepays fundamental ratios Correlations

Surgepays Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Surgepays fundamental ratios Accounts

Currently Active Assets on Macroaxis

Complementary Tools for Surgepays Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Common Stock Shares Outstanding	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Common Stock Shares Outstanding
Net Receivables	+ 0.98	Total Assets
Net Receivables	+ 0.98	Common Stock Shares Outstanding

Net Debt	- 0.92	Total Stockholder Equity
Total Liab	- 0.9	Retained Earnings
Retained Earnings	- 0.87	Other Current Liab
Retained Earnings	- 0.86	Total Current Liabilities
Short Long Term Debt Total	- 0.85	Retained Earnings
Accounts Payable	- 0.84	Retained Earnings